Coherus BioSciences (NASDAQ:CHRS) Upgraded at StockNews.com
StockNews.com upgraded shares of Coherus BioSciences (NASDAQ:CHRS – Free Report) from a sell rating to a hold rating in a research report sent to investors on Thursday morning. A number of other analysts also recently weighed in on CHRS. HC Wainwright reiterated a “buy” rating and set a $7.00 target price on shares of Coherus […]
StockNews.com upgraded shares of Coherus BioSciences (NASDAQ:CHRS – Free Report) from a sell rating to a hold rating in a research report sent to investors on Thursday morning. A number of other analysts also recently weighed in on CHRS. HC Wainwright reiterated a “buy” rating and set a $7.00 target price on shares of Coherus […]
